In this post, I told you about the FDA/FTC warning letter to Dr. Andrew Weil. In this post, I want to tell you about the voluntary suspension of a food labeling program by the above companies. The suspension is the ultimate result of a letter from the FDA to the companies (see here) which called into question claims made through the program.
Specifically, that such programs may mislead consumers about the health benefits of certain foods, and it told manufacturers it will crack down on inaccurate labeling. It did not criticize specific products or label programs or give a timeline for enforcement.
This development is more clear evidence that the FDA is taking an entirely new approach to reviewing the labels of products it regulates.
I have scheduled an IBN member conference call to review applicable laws on November 5 at noon New York Time.